| 产品详情 |
| Edit |   |
|---|
| Product Name | LIMKi 3 |
|---|
| Description | LIMKi 3 is a potent, and cell-permeable inhibitor of LIMK1 (IC50 = 7 nM) and LIMK2 (IC50 = 8 nM) and inhibits coflin phosphorylation in MDA-MB-231 breast cancer cells without affecting tubulin polymerization or inducing cytotoxicity. It also reduces MDA-MB-231 tumor cell invasion in a 3D matrigel invasion assay. MW: 431.29. Purity ≥98% by HPLC |
|---|
| Size | 25 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | N-[5-[1-(2,6-Dichlorophenyl)-3-(difluoromethyl)-1H-pyrazol-5-yl]-2-thiazolyl]-2-methylpropanamide ; BMS 5 |
|---|
| Gene, Accession, CAS # | CAS: 1338247-35-0 |
|---|
| Catalog # | B1095-25 |
|---|
| Price | |
|---|
| Order / More Info | LIMKi 3 from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|